gentiopicroside has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, H; Wang, Z; Xiong, K; Xu, L; Zhang, T | 1 |
| Gong, J; Han, H; Tang, X; Wang, Z; Yang, F; Yang, L; Yang, Q | 1 |
2 other study(ies) available for gentiopicroside and Bile Duct Obstruction
| Article | Year |
|---|---|
Exploration of Hepatoprotective Effect of Gentiopicroside on Alpha-Naphthylisothiocyanate-Induced Cholestatic Liver Injury in Rats by Comprehensive Proteomic and Metabolomic Signatures.
Topics: 1-Naphthylisothiocyanate; Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Discriminant Analysis; Gene Expression Regulation; Iridoid Glucosides; Male; Metabolome; Metabolomics; PPAR alpha; Principal Component Analysis; Protective Agents; Proteome; Proteomics; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Retinoid X Receptor alpha | 2018 |
Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
Topics: 1-Naphthylisothiocyanate; Animals; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestasis; Homeostasis; Iridoid Glucosides; Liver; Mice; Mice, Inbred C57BL | 2016 |